Related Resources from Other PEPFAR Partners
Costing Male Circumcision in Lesotho, Swaziland, and Zambia
Clinical trials have now confirmed the efficacy of male circumcision (MC) in reducing female-to-male transmission. Some cost data have been reported (ranging between US$25 and US $69), and these cost data also formed the basis of a cost-effectiveness analysis. It is unclear, however, what exactly is included in the costing studies and hence whether these costs are directly comparable. For example, often indirect costs are not fully reflected; donations (especially clinicians' time) are not costed; and variation by provider type and level of health facility is not considered. It is anticipated that this cost analysis will provide a more detailed examination of the costs of MC and inform a sounder basis for an assessment of the cost-effectiveness of MC and planning for the implementation of MC. The analysis has three components: (1) conducting key informant interviews to better understand the social, cultural, and policy context of MC; (2) costing MC; and (3) modeling the impact of MC on the HIV epidemic. The qualitative component was only carried out in Lesotho and Swaziland, and results from these interviews can be found in the individual country reports.